Silo Pharma, Inc. (SILO) financial statements and ratios from SEC XBRL: revenue $72102.00 (TTM), net margin -5863.5%, revenue growth 0.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $72102.00 |
| Net Margin | -5863.5% |
| Revenue Growth (YoY) | 0.0% |
| EPS Growth (YoY) | -58.0% |
| Price / Book | 7.67 |
| Price / Sales | 604.62 |
| Altman Z-Score | 13.15 (safe) |
| Sector P/E (Healthcare) | 21.7 |
SILO overview · SILO earnings · SILO KPIs · SILO investor relations · SILO ownership · SILO peers · SILO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.